Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the health-check domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /dom76025/wp-includes/functions.php on line 6121
July 29, 2024 - Page 2 of 4 - The Dermatology Digest
Subscribe
Search

Day: July 29, 2024

Enrollment Complete in Phase 3 Study of Brepocitinib in DM

Enrollment in Phase 3 VALOR study evaluating brepocitinib in dermatomyositis is now complete, according to Priovant Therapeutics. Data are anticipated in the second half of calendar year 2025, with a potential New Drug Application (NDA) submission to follow. Brepocitinib is a dual selective inhibitor of oral tyrosine kinase 2 (TYK2) inhibitor and Janus kinase (JAK1) […]